COUR vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

COUR

67.1
AI Score
VS
COUR Wins

DOCS

48.1
AI Score

Investment Advisor Scores

COUR

67score
Recommendation
HOLD

DOCS

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric COUR DOCS Winner
Forward P/E 6.2422 19.7628 COUR
PEG Ratio 0 0.5895 Tie
Revenue Growth 59.6% 7.3% COUR
Earnings Growth 0.0% -51.9% COUR
Tradestie Score 67.1/100 48.1/100 COUR
Profit Margin -15.4% 25.5% DOCS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

COUR 1M: -5.9% · 3M: -10.2% DOCS 1M: +26.7% · 3M: +64.2%

Current Technical Phase

COUR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $4.82

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 75

RSI (14): 74.6 · Price: $33.58

Fundamentals Snapshot

Metric COUR DOCS
Market Cap — —
Forward P/E 6.0 20.7
Trailing P/E — 39.2
Revenue (TTM) — —
Revenue Growth 0.6% 0.1%
Gross Margin 0.6% 0.9%
Operating Margin 0.0% 0.2%
EPS -0.71 0.85
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, COUR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.